German firm tests 'double chin' drug

Jan 10, 2011

German drugs giant Bayer said Monday it had launched tests into an injectable drug to combat the fat deposits that lead to the dreaded "double chin."

Bayer said in a statement it was conducting clinical trials into ATX-101, an injectable "for the reduction of localised under the chin (submental fat)."

The firm is testing some 720 people in 64 centres in Britain, France, Germany, Belgium, Spain and Italy with a view to launching a product in Europe, Asia and South America in 2014.

Jean-Paul Ortonne, a French involved in the trials, said: "There is a huge demand for a safe, effective and approved injectable treatment for localised fat reduction."

The tests are a step towards "a well-studied, clinically-proven treatment to reduce localised submental fat without surgery," he added.

Yvonne Moeller, a Bayer spokeswoman, described the procedure as "something like a tattoo."

Between 40 and 70 tiny injections are administered into the over several sessions, with the amount depending on the size of the double chin and the person, she told AFP.

"You would hope to see noticeable results after about 16 weeks," she added.

Explore further: Mirabegron for overactive bladder: Added benefit not proven

add to favorites email to friend print save as pdf

Related Stories

Red pepper: Hot stuff for fighting fat?

Mar 05, 2007

Food scientists in Taiwan are reporting new evidence from laboratory experiments that capsaicin — the natural compound that gives red pepper that spicy hot kick — can reduce the growth of fat cells. The study is scheduled ...

FDA cracking down on fat-melting injections

Apr 07, 2010

(AP) -- The Food and Drug Administration is cracking down on fat-melting injections used in spas across the U.S., saying the drugs have not been proven safe or effective.

Human virus makes fat stem cells fatter

Oct 25, 2006

U.S. research showing how a human virus targets fat stem cells to produce more, fatter, fat cells is providing insights into the study of obesity.

New insights into how natural antioxidants fight fat

Nov 05, 2007

Scientists in Taiwan are reporting new insights into why diets rich in fruits and vegetables reduce the risk of obesity. Their study, scheduled for the Oct. 17 (current) issue of ACS’ Journal of Agricultural an ...

Enzyme promotes fat formation

Oct 12, 2007

The enzyme TPPII may contribute to obesity by stimulating the formation of fat cells, suggests a study in EMBO reports this week. The enzyme, TPPII, has previously been linked to making people feel hungry, but Jonathan Graff ...

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

4 hours ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

geokstr
1 / 5 (1) Jan 10, 2011
Doctors in Beverly Hills will form a partnership to buy out the patent for this drug. After all, they've already invented a highly lucrative fix for this self-image-threatening condition.